The Effect of Age on High-Dose Therapy with Autologous Stem Cell Support in Multiple Myeloma: A Single-Center Experience.

Autor: Erdogan Yucel E; Department of Hematology, University of Health Science, Izmir City Hospital, 35180 Izmir, Turkey., Kirmaz AT; Department of Internal Medicine, Dokuz Eylul University, 35220 Izmir, Turkey., Kakci M; Department of Hematology, Dokuz Eylul University, 35220 Izmir, Turkey., Yavuz AF; Department of Hematology, Dokuz Eylul University, 35220 Izmir, Turkey., Sencelikel T; Department of Biostatistics, Medipol University, Ankara 34810, Turkey., Alacacioglu I; Department of Hematology, Dokuz Eylul University, 35220 Izmir, Turkey., Ozsan GH; Department of Hematology, Dokuz Eylul University, 35220 Izmir, Turkey.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Jul 16; Vol. 13 (14). Date of Electronic Publication: 2024 Jul 16.

PB2007: FACTORS ASSOCIATED WITH EARLY RELAPSE IN MYELOMA PATIENTS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION.

Autor: Karatas, A., Yavuz, B., Erdogan Yucel, E., Kakci, M., Ozsan, G. H., Alacacioglu, I., Demirkan, F.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p1878-1879, 2p

Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy.

Autor: Woo, Timothy, Carter, Matthew, Follows, George, Patten, Piers E. M.

Publikováno v: Frontiers in Oncology; 2023, p1-5, 5p